Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 17, Number 8—August 2011

Research

Seroprevalence of Trichodysplasia Spinulosa–associated Polyomavirus

Els van der MeijdenComments to Author , Siamaque Kazem, Manda M. Burgers, Rene Janssens, Jan Nico Bouwes Bavinck, Hester E. de Melker, and Mariet C.W. Feltkamp
Author affiliations: Author affiliations: Leiden University Medical Center, Leiden, the Netherlands (E. van der Meijden, S. Kazem, M.M. Burgers, J.N. Bouwes Bavinck, M.C.W. Feltkamp); Jeroen Bosch Ziekenhuis, ‘s Hertogenbosch, the Netherlands (R. Janssens); National Institute of Public Health and the Environment, Bilthoven, the Netherlands (H. de Melker)

Main Article

Figure 5

Seroresponses against trichodysplasia spinulosa–associated polyomavirus (TSV) (A) and BKV polyomavirus (B) for a patient with trichodysplasia spinulosa, the Netherlands. Serial dilutions of serum from a TS patient were tested for reactivity against TSV viral protein 1 (VP1) or BKV VP1 by using the VP1 multiplex antibody-binding assay. Samples were preincubated with soluble recombinant glutathione-S-transferase (GST) (black line), GST-BKV VP1 (red line), or GST-TSV VP1 (blue line). MFI, median fl

Figure 5. Seroresponses against trichodysplasia spinulosa–associated polyomavirus (TSV) (A) and BKV polyomavirus (B) for a patient with trichodysplasia spinulosa, the Netherlands. Serial dilutions of serum from a TS patient were tested for reactivity against TSV viral protein 1 (VP1) or BKV VP1 by using the VP1 multiplex antibody-binding assay. Samples were preincubated with soluble recombinant glutathione-S-transferase (GST) (black line), GST-BKV VP1 (red line), or GST-TSV VP1 (blue line). MFI, median fluorescent intensity.

Main Article

Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external